Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEAL: Calcitriol and Losartan in Diabetic Nephropathy
NCT02410005Phase 3Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2014
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of calcitriol in diabetic nephropathy (DN), sponsored by Weill Cornell Medicine. Started Oct 2014; status: terminated.
02
Drugs
calcitriol
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02410005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02410005.